32 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 May 24
Current report (foreign)
4:03pm
, by the Chief Executive Officer of the Company).
Director Independence
Based upon information requested from and provided by each director concerning … satisfy the independence standards for such committees established by the SEC and Nasdaq listing standards, as applicable. With respect to the audit
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
knowledge, the Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jul 23
Current report (foreign)
3:49pm
who requests them from our Corporate Secretary (or, in the absence thereof, by the Chief Executive Officer of the Company).
Director Independence … the compensation committee and the corporate governance and nominating committee, each satisfy the independence standards for such committees established by the SEC
8-K/A
qtea4lvr
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
424B3
jeu15c 53
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
svbp8n6f4itu1zt
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
z97plji
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
DEF 14A
o6aiqx2a 2gpxdz0p
6 Apr 20
Definitive proxy
6:11am
PRE 14A
9evdwi lnvrot2xzgamb
30 Mar 20
Preliminary proxy
5:03pm